{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$19.42B vs. cons $19.28B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$7.32 vs. cons $7.15",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "MISS",
      "answer": "pred ~$0.35B vs. cons $0.80B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 sales guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$78.75B vs. cons $78.80B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 diluted EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$29.80 vs. cons $30.00 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free-cash-flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$6.65B vs. cons $6.65B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -1.5,
  "day5_path": "STABILIZE",
  "day5_rationale": "A ~$0.17 EPS beat versus $7.15 and ~$0.14B revenue beat versus $19.28B should be outweighed initially by a ~$0.45B quarterly FCF shortfall versus $0.80B and an unchanged ~$6.65B FY2026 FCF guide versus $6.65B consensus. With FY2026 sales guide near $78.75B versus $78.80B consensus and EPS guide near $29.80 versus $30.00, out-period estimate cuts should be limited; the initial cash-conversion disappointment is therefore more likely to stabilize than drive a continuing revision-led selloff.",
  "day5_confidence": "MEDIUM"
}